WEIGHT LOSS FROM WEGOVY SUSTAINED FOR UP TO FOUR YEARS, TRIAL SHOWS

Summary from the TLDR newsletter

A large long-term trial of semaglutide found that early weight loss from the drug is generally maintained for up to four years, with the participants in the study receiving weekly injections. The participants in the study tended to lose weight over the first 65 weeks on the drug but then hit a plateau. Semaglutide reduced participants' risk of heart attack, stroke, and cardiovascular-related deaths by 20% over the span of a little over three years. 52.4% of participants who received the drug in the study moved to a lower category of body mass index during the trial.